CNS Pharmaceuticals News and Activities

View the org chart displaying its 11 main executives

Most searched biographies at CNS Pharmaceuticals

• Rami Levin, Chief Executive Officer and Director
• George Gumulka, Independent Director
• Amy Mahery, Director

Popular executive movements at CNS Pharmaceuticals

• Dylan Wenke has joined the company as Chief Business Officer  (posted on March 4 2026).
• Sandra Silberman, Chief Medical Officer, has left the company  (posted on March 4 2026).
• Steve O'Loughlin has joined the company as Chief Financial Officer  (posted on March 4 2026).

Click here to view some more movements at CNS Pharmaceuticals

Create your alert
to follow the executive moves at CNS Pharmaceuticals.

CNS Pharmaceuticals has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by CNS Pharmaceuticals

• Press Releases | CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• View more press releases Close

Social media about CNS Pharmaceuticals

• CNS Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• CNS Pharmaceuticals on LinkedIn, X (Twitter) & YouTube